SELECT COUNTRY

VIEW ALL
AFRICA
AMERICAS
ASIA
EUROPE
OCEANIA

UNITED STATES: LATEST INTERVIEWS MORE INTERVIEWS

Dr. Andrea Pfeiffer
CO-FOUNDER & CEO, AC IMMUNE
AC Immune describes its research into neurodegenerative diseases.
United States
Pharmaceuticals
Mark Egerton
CEO, QUOTIENT SCIENCES
Quotient Sciences is a drug development and manufacturing accelerator that supports pharmaceutical and biotech companies with services spanning the entire development pathway from candidate selection to commercial launch.
United States
Pharmaceuticals
Jay Shukla
PRESIDENT & CEO, NIVAGEN PHARMACEUTICALS, INC.
Nivagen Pharmaceuticals provides complete research, analytical formulation development, and regulatory support.
United States
Pharmaceuticals
Dr. Jagadeesh Babu Rangisetty
FOUNDER & CEO, BIOPHORE
Biophore explains how it is expanding productions of different APIs to ensure both quality and supply chain security.
United States
Pharmaceuticals

UNITED STATES: LATEST ARTICLES

United States
Pharmaceuticals

Funding Environment: Life Sciences Enter the Mainstream

April 20, 2021
The past 12 months been transformative for the life science industry in USA, and GBR explores how the funding environment has evolved to provide the influx of capital to sustain its innovations.
United States
Pharmaceuticals

US Biopharmaceutical Investment Climate

June 17, 2020
United States Biopharmaceuticals 2020
Robust M&A displays value despite pushback.
United States
Pharmaceuticals

Introducing the U.S. Biopharmaceutical Industry

May 14, 2020
United States Biopharmaceuticals 2019
The moral imperative to innovate.
MORE ARTICLES

UNITED STATES: RECENTLY RELEASED PUBLICATIONS

AI in the Life Sciences 2020

October 01, 2020

United States Biopharmaceuticals 2020

May 15, 2020

United States Biopharmaceuticals 2019

April 24, 2019

MACIG

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

Mining in Ontario and Toronto's Global Reach 2021

MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL